Lowrey King, MD
Ophthalmology · Charleston, SCNPI 1962446427
Payments from drug & device makers
Across 29 payments — averaging $28.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beaver-visitec International, Inc.$246
- Astellas Pharma US Inc$146
- Dutch Ophthalmic, USA$79
- Alimera Sciences, Inc.$66
- Coherus Oncology, Inc.$57
- Genentech USA, Inc.$39
- plus $189 from 8 others
What the payments were for
- Food & beverage$821100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beaver-visitec International, Inc. | 1 | $246 |
| Astellas Pharma US Inc | 7 | $146 |
| Dutch Ophthalmic, USA | 3 | $79 |
| Alimera Sciences, Inc. | 5 | $66 |
| Coherus Oncology, Inc. | 2 | $57 |
| Genentech USA, Inc. | 3 | $39 |
| Lensar, Inc. | 1 | $34 |
| Glaukos Corporation | 1 | $31 |
| Harrow Eye, LLC | 1 | $27 |
| Novartis | 1 | $26 |
| AbbVie | 1 | $22 |
| Notal Vision, Inc. | 1 | $18 |
| Rayner Intraocular Lenses Limited | 1 | $16 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $15 |
How this compares
$821 in reported general payments places this provider in the 30th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 275 | $15,187 |
| Ofloxacin | 185 | $3,474 |
| Bromfenac Sodium | 25 | $3,039 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 17 | $2,711 |
| Ketorolac Tromethamine | 50 | $1,549 |
| Brimonidine Tartrate | 33 | $972 |
| Latanoprost | 23 | $333 |
| Timolol Maleate | 14 | $140 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Charleston
- Daniel AlfaroCharleston$4.6M
- Eric JablonCharleston$1.2M
- John KerrisonCharleston$975K
- Karolinne RochaCharleston$799K
- Mona CamacciCharleston$534K
- Marion WilsonCharleston$86K
- Drew DicksonCharleston$53K
- Michael JohnsonCharleston$23K
- Karen FernandezCharleston$22K
- Cole MillikenCharleston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.